Trial Profile
Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Nephrotic syndrome; Renal failure
- Focus Biomarker; Pharmacodynamics; Proof of concept; Therapeutic Use
- 08 Feb 2017 Status changed from recruiting to discontinued.
- 06 Jul 2015 New trial record